Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (Q71849285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

J J Eron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M A Ashby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M F Giordano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Chernow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

W M Reiter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S G Deeks

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J P Lavelle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M A Conant

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

B G Yangco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P G Pate

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R A Torres

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R T Mitsuyasu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

T Twaddell

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1547-1551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

9041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

A strategy for prophylactic vaccination against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Planning a longitudinal study. II. Frequency of measurement and study duration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Size and power of two-sample tests of repeated measures data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905283-X

7 January 2021

10.1016/S0140-6736(96)05283-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950881%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference